申请人:THE SCRIPPS RESEARCH INSTITUTE
公开号:US20170029454A1
公开(公告)日:2017-02-02
Alpha-glycosylceramide compounds capable of activating NKT cells and compositions thereof are disclosed. Methods for activating NKT cells, methods of stimulating an immune response in a subject, and methods of treating cancer, infectious diseases, autoimmune diseases and disorders, or allergy diseases or disorders with the compounds and compositions are also disclosed.